Bioactivity:

DCLX069 is a potent and selective PRMT1 inhibitor. DCLX069 occupies the SAM binding pocket to exert the inhibitory effect. DCLX069 effectively blocks cell proliferation in breast cancer, liver cancer and acute myeloid leukemia cell lines.

CAS nr:

792946-69-1

Purity:

98%

Molecular Weight:

339,44

SMILES:

O=C(OCC)C1=CC=C(N2CCN(CC3=CC=CC=C3)CC2)C(N)=C1

Formula:

C20H25N3O2

Pathway:

Chromatin/Epigenetic

Target:

Histone Methyltransferase